DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
0 hedge funds and large institutions have $0 invested in DermTech, Inc. Common Stock in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $38 → $0 (-$38)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T2I
Turim 21 Investimentos
Rio De Janeiro,
Brazil
|
-$38 |
DMTK Hedge Fund Activity: Q4 2025 in Review
0 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q4 2025, worth a combined $0 — down 100% from $38 a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of DMTK and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Turim 21 Investimentos, exiting entirely with an estimated $38 sold.
- 0 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q4 2025, down from 2 in Q3 2025.
- Funds reported $0 of DermTech, Inc. Common Stock stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new DermTech, Inc. Common Stock positions in Q4 2025 and 2 closed out, a net change of -2 holders.
- The largest DermTech, Inc. Common Stock seller in Q4 2025 was Turim 21 Investimentos, an estimated $38 sold.
Based on aggregated 13F filings for Q4 2025.